Children treated with certain chemotherapy drugs or alkylating agents, including cyclophosphamide, ifosfamide, busulfan, and temozolomide, experience an increased risk of bladder cancer. Survivors of heritable
Although rare, some pediatric cancer treatments can cause another cancer to develop later in life. For survivors, skin cancer is the most common of these
Sometimes, despite the best care and significant treatment progress, cancer returns. COG provides an overview of how to respond should this unfortunate reality occur.
If cancer recurs, parents, patients (when old enough), and the care team must decide about the following treatment course. Families must deal with the emotions
After a battle with childhood cancer, the last thing someone wants to consider is the risk of developing a second cancer. However, the COG and
Research has shown that the risk for a second cancer is slightly higher for childhood cancer survivors than the risk for cancer in people of
This resource provides highly respected, evidence-based knowledge about childhood cancers and includes a section on Second Cancers. It summarizes the topic and contains current information
As childhood cancer survivors become older, they have a slightly higher risk of developing (a second) cancer than people their age in the general population.
Women treated with radiation to the chest for cancer during childhood, adolescence, or young adulthood have an increased risk of developing breast cancer as they
Some childhood and AYA cancer survivors have a higher risk of developing breast cancer. This resource examines various risk factors and breast cancer screening guidelines.
